A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy

Richard J. Gralla, S. M. Bosnjak, A. Hontsa, C. Balser, G. Rizzi, G. Rossi, M. E. Borroni, K. Jordan

Research output: Contribution to journalArticlepeer-review

135 Scopus citations

Fingerprint

Dive into the research topics of 'A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences